United States Drug Repositioning Market Report & Forecast 2021-2027

Publisher Name :
Date: 10-Sep-2021
No. of pages: 91
Inquire Before Buying

United States Drug Repositioning Market, By Type, 2016-2021, 2022-2027 ($ Millions)

United States Drug Repositioning Market Segment Percentages, By Type, 2020 (%)

- Generic Drugs

- Clinical Trial Failed Drugs

United States Drug Repositioning Market, By Application, 2016-2021, 2022-2027 ($ Millions)

United States Drug Repositioning Market Segment Percentages, By Application, 2020 (%)

- Cardiovascular Diseases

- Mental Illness

- Cancer

- Others

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Drug Repositioning revenues in United States market, 2016-2021 (Estimated), ($ millions)

Key companies Drug Repositioning revenues share in United States market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Teva

- Novartis

- Mylan

- Johnson & Johnson

- Pfizer

- Bausch Health

- GSK

- ChemRar Group

- Glenmark

- Fujifilm

- Dr. Reddy

- R-Pharma

United States Drug Repositioning Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Drug Repositioning Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Drug Repositioning Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Drug Repositioning Overall Market Size
2.1 United States Drug Repositioning Market Size: 2021 VS 2027
2.2 United States Drug Repositioning Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Drug Repositioning Players in United States Market
3.2 Top United States Drug Repositioning Companies Ranked by Revenue
3.3 United States Drug Repositioning Revenue by Companies
3.4 Top 3 and Top 5 Drug Repositioning Companies in United States Market, by Revenue in 2020
3.5 Companies Drug Repositioning Product Type
3.6 Tier 1, Tier 2 and Tier 3 Drug Repositioning Players in United States Market
3.6.1 List of Tier 1 Drug Repositioning Companies in United States
3.6.2 List of Tier 2 and Tier 3 Drug Repositioning Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Drug Repositioning Market Size Markets, 2021 & 2027
4.1.2 Generic Drugs
4.1.3 Clinical Trial Failed Drugs
4.2 By Type - United States Drug Repositioning Revenue & Forecasts
4.2.1 By Type - United States Drug Repositioning Revenue, 2016-2021
4.2.2 By Type - United States Drug Repositioning Revenue, 2022-2027
4.2.3 By Type - United States Drug Repositioning Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Drug Repositioning Market Size, 2021 & 2027
5.1.2 Cardiovascular Diseases
5.1.3 Mental Illness
5.1.4 Cancer
5.1.5 Others
5.2 By Application - United States Drug Repositioning Revenue & Forecasts
5.2.1 By Application - United States Drug Repositioning Revenue, 2016-2021
5.2.2 By Application - United States Drug Repositioning Revenue, 2022-2027
5.2.3 By Application - United States Drug Repositioning Revenue Market Share, 2016-2027
6 Drug Repositioning Companies Profiles
6.1 Teva
6.1.1 Teva Company Details
6.1.2 Teva Business Overview
6.1.3 Teva Drug Repositioning Introduction
6.1.4 Teva Drug Repositioning Revenue in United States Market (2016-2021)
6.1.5 Teva Recent Developments
6.2 Novartis
6.2.1 Novartis Company Details
6.2.2 Novartis Business Overview
6.2.3 Novartis Drug Repositioning Introduction
6.2.4 Novartis Drug Repositioning Revenue in United States Market (2016-2021)
6.2.5 Novartis Recent Developments
6.3 Mylan
6.3.1 Mylan Company Details
6.3.2 Mylan Business Overview
6.3.3 Mylan Drug Repositioning Introduction
6.3.4 Mylan Drug Repositioning Revenue in United States Market (2016-2021)
6.3.5 Mylan Recent Developments
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Company Details
6.4.2 Johnson & Johnson Business Overview
6.4.3 Johnson & Johnson Drug Repositioning Introduction
6.4.4 Johnson & Johnson Drug Repositioning Revenue in United States Market (2016-2021)
6.4.5 Johnson & Johnson Recent Developments
6.5 Pfizer
6.5.1 Pfizer Company Details
6.5.2 Pfizer Business Overview
6.5.3 Pfizer Drug Repositioning Introduction
6.5.4 Pfizer Drug Repositioning Revenue in United States Market (2016-2021)
6.5.5 Pfizer Recent Developments
6.6 Bausch Health
6.6.1 Bausch Health Company Details
6.6.2 Bausch Health Business Overview
6.6.3 Bausch Health Drug Repositioning Introduction
6.6.4 Bausch Health Drug Repositioning Revenue in United States Market (2016-2021)
6.6.5 Bausch Health Recent Developments
6.7 GSK
6.7.1 GSK Company Details
6.7.2 GSK Business Overview
6.7.3 GSK Drug Repositioning Introduction
6.7.4 GSK Drug Repositioning Revenue in United States Market (2016-2021)
6.7.5 GSK Recent Developments
6.8 ChemRar Group
6.8.1 ChemRar Group Company Details
6.8.2 ChemRar Group Business Overview
6.8.3 ChemRar Group Drug Repositioning Introduction
6.8.4 ChemRar Group Drug Repositioning Revenue in United States Market (2016-2021)
6.8.5 ChemRar Group Recent Developments
6.9 Glenmark
6.9.1 Glenmark Company Details
6.9.2 Glenmark Business Overview
6.9.3 Glenmark Drug Repositioning Introduction
6.9.4 Glenmark Drug Repositioning Revenue in United States Market (2016-2021)
6.9.5 Glenmark Recent Developments
6.10 Fujifilm
6.10.1 Fujifilm Company Details
6.10.2 Fujifilm Business Overview
6.10.3 Fujifilm Drug Repositioning Introduction
6.10.4 Fujifilm Drug Repositioning Revenue in United States Market (2016-2021)
6.10.5 Fujifilm Recent Developments
6.11 Dr. Reddy
6.11.1 Dr. Reddy Company Details
6.11.2 Dr. Reddy Business Overview
6.11.3 Dr. Reddy Drug Repositioning Introduction
6.11.4 Dr. Reddy Drug Repositioning Revenue in United States Market (2016-2021)
6.11.5 Dr. Reddy Recent Developments
6.12 R-Pharma
6.12.1 R-Pharma Company Details
6.12.2 R-Pharma Business Overview
6.12.3 R-Pharma Drug Repositioning Introduction
6.12.4 R-Pharma Drug Repositioning Revenue in United States Market (2016-2021)
6.12.5 R-Pharma Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
Table 1. Drug Repositioning Market Opportunities & Trends in United States Market
Table 2. Drug Repositioning Market Drivers in United States Market
Table 3. Drug Repositioning Market Restraints in United States Market
Table 4. Key Players of Drug Repositioning in United States Market
Table 5. Top Drug Repositioning Players in United States Market, Ranking by Revenue (2019)
Table 6. United States Drug Repositioning Revenue by Companies, (US$, Mn), 2016-2021
Table 7. United States Drug Repositioning Revenue Share by Companies, 2016-2021
Table 8. Companies Drug Repositioning Product Type
Table 9. List of Tier 1 Drug Repositioning Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Drug Repositioning Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - United States Drug Repositioning Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - United States Drug Repositioning Revenue (US$, Mn), 2016-2021
Table 13. By Type - United States Drug Repositioning Revenue (US$, Mn), 2022-2027
Table 14. By Application - United States Drug Repositioning Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - United States Drug Repositioning Revenue (US$, Mn), 2016-2021
Table 16. By Application - United States Drug Repositioning Revenue (US$, Mn), 2022-2027
Table 17. Teva Company Details
Table 18. Teva Business Overview
Table 19. Teva Drug Repositioning Product
Table 20. Teva Drug Repositioning Revenue in United States Market (2016-2021) & (US$ Million)
Table 21. Teva Recent Developments
Table 22. Novartis Company Details
Table 23. Novartis Business Overview
Table 24. Novartis Drug Repositioning Product
Table 25. Novartis Drug Repositioning Revenue in United States Market (2016-2021) & (US$ Million)
Table 26. Novartis Recent Developments
Table 27. Mylan Company Details
Table 28. Mylan Business Overview
Table 29. Mylan Drug Repositioning Product
Table 30. Mylan Drug Repositioning Revenue in United States Market (2016-2021) & (US$ Million)
Table 31. Mylan Recent Developments
Table 32. Johnson & Johnson Company Details
Table 33. Johnson & Johnson Business Overview
Table 34. Johnson & Johnson Drug Repositioning Product
Table 35. Johnson & Johnson Drug Repositioning Revenue in United States Market (2016-2021) & (US$ Million)
Table 36. Johnson & Johnson Recent Developments
Table 37. Pfizer Company Details
Table 38. Pfizer Business Overview
Table 39. Pfizer Drug Repositioning Product
Table 40. Pfizer Drug Repositioning Revenue in United States Market (2016-2021) & (US$ Million)
Table 41. Pfizer Recent Developments
Table 42. Bausch Health Company Details
Table 43. Bausch Health Business Overview
Table 44. Bausch Health Drug Repositioning Product
Table 45. Bausch Health Drug Repositioning Revenue in United States Market (2016-2021) & (US$ Million)
Table 46. Bausch Health Recent Developments
Table 47. GSK Company Details
Table 48. GSK Business Overview
Table 49. GSK Drug Repositioning Product
Table 50. GSK Drug Repositioning Revenue in United States Market (2016-2021) & (US$ Million)
Table 51. GSK Recent Developments
Table 52. ChemRar Group Company Details
Table 53. ChemRar Group Business Overview
Table 54. ChemRar Group Drug Repositioning Product
Table 55. ChemRar Group Drug Repositioning Revenue in United States Market (2016-2021) & (US$ Million)
Table 56. ChemRar Group Recent Developments
Table 57. Glenmark Company Details
Table 58. Glenmark Business Overview
Table 59. Glenmark Drug Repositioning Product
Table 60. Glenmark Drug Repositioning Revenue in United States Market (2016-2021) & (US$ Million)
Table 61. Glenmark Recent Developments
Table 62. Fujifilm Company Details
Table 63. Fujifilm Business Overview
Table 64. Fujifilm Drug Repositioning Product
Table 65. Fujifilm Drug Repositioning Revenue in United States Market (2016-2021) & (US$ Million)
Table 66. Fujifilm Recent Developments
Table 67. Dr. Reddy Company Details
Table 68. Dr. Reddy Business Overview
Table 69. Dr. Reddy Drug Repositioning Product
Table 70. Dr. Reddy Drug Repositioning Revenue in United States Market (2016-2021) & (US$ Million)
Table 71. Dr. Reddy Recent Developments
Table 72. R-Pharma Company Details
Table 73. R-Pharma Business Overview
Table 74. R-Pharma Drug Repositioning Product
Table 75. R-Pharma Drug Repositioning Revenue in United States Market (2016-2021) & (US$ Million)
Table 76. R-Pharma Recent Developments
List of Figures
Figure 1. Drug Repositioning Segment by Type
Figure 2. Drug Repositioning Segment by Application
Figure 3. United States Drug Repositioning Market Overview: 2020
Figure 4. United States Drug Repositioning Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. United States Drug Repositioning Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Drug Repositioning Revenue in 2020
Figure 7. By Type - United States Drug Repositioning Revenue Market Share, 2016-2027
Figure 8. By Application - United States Drug Repositioning Revenue Market Share, 2016-2027
Figure 9. Teva Drug Repositioning Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Novartis Drug Repositioning Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Mylan Drug Repositioning Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Johnson & Johnson Drug Repositioning Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Pfizer Drug Repositioning Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Bausch Health Drug Repositioning Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. GSK Drug Repositioning Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. ChemRar Group Drug Repositioning Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Glenmark Drug Repositioning Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. Fujifilm Drug Repositioning Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 19. Dr. Reddy Drug Repositioning Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 20. R-Pharma Drug Repositioning Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
  • Global Public and Personal Safety Industry Research Report, Growth Trends and Competitive Analysis 2023-2029
    Published: 11-Jan-2024        Price: US 5600 Onwards        Pages: 177
    The global Public and Personal Safety Industry market size was US$ 6,398.95 million in 2022 and is forecast to a readjusted size of US$ 18,265.36 million by 2029 with a CAGR of 16.88% during the forecast period 2023-2029. The global key companies of Public and Personal Safety Industry include Hexagon, Motorola Solutions Inc, NEC, Tyler Technologies Inc and Indra Sistemas, accounting for 24.50% market share in terms of revenues in 2022. The market research report offered here is a v......
  • Global Digital Watermark Technology Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global market for Digital Watermark Technology estimated was at US$ 111.3 million in the year 2022, is projected to reach a revised size of US$ 210.53 million by 2029, growing at a CAGR of 9.4% during the forecast period 2023-2029. North American market for Digital Watermark Technology was valued at $ 39.07 million in 2022 and will reach $ 68.79 million by 2029, at a CAGR of 8.2 % during the forecast period of 2023 through 2029. Asia-Pacific market for Digital Watermark Technol......
  • Global Location Based Marketing Services Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Location Based Marketing Services market was valued at US$ 46700 million in 2023 and is anticipated to reach US$ 144870 million by 2030, witnessing a CAGR of 17.2% during The forecast period 2024-2030. North American market for Location Based Marketing Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Location Based Marketing Services is estima......
  • Global Auto Repair and Beauty Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 72
    The global Auto Repair and Beauty market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. Automotive is a key driver of this industry. According to data from The World Automobile Organization (OICA), global automobile production and sales in 2017 reached their peak in The past 10 years, at 97.3 million and 95.89 million respectively. In 2018, The global economic expansion ended, and The gl......
  • Global Viral Vector Development Service Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global Viral Vector Development Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Viral Vector Development Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Viral Vector Development Service is estimated to increase from......
  • Global Building Automation Systems (BAS) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Building Automation Systems (BAS) market was valued at US$ 75680 million in 2023 and is anticipated to reach US$ 143970 million by 2030, witnessing a CAGR of 9.5% during The forecast period 2024-2030. North American market for Building Automation Systems (BAS) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Building Automation Systems (BAS) is estimat......
  • Global SLAM in Mobile Robots and Smart AR Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 92
    This report studies The SLAM Robots market, Simultaneous localization and mapping, or SLAM for short, is The process of creating a map using a robot or unmanned vehicle that navigates that environment while using The map it generates. SLAM is technique behind robot mapping or robotic cartography. The robot or vehicle plots a course in an area, but at The same time, it also has to figure out where its own self is located in The place. The process of SLAM uses a complex array of computations, algo......
  • Global Digital Educational Publishing Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Digital Educational Publishing market was valued at US$ 8324.5 million in 2023 and is anticipated to reach US$ 14580 million by 2030, witnessing a CAGR of 7.9% during The forecast period 2024-2030. North American market for Digital Educational Publishing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Digital Educational Publishing is estimated to inc......
  • Global Human Source Service Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The global Human Source Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Human Source Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Human Source Service is estimated to increase from $ million in 2023 to reach $ millio......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs